Los Angeles Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.66M | Buy |
26,638
+1,709
| +7% | +$235K | 0.01% | 352 |
|
|
2025
Q1 | $4.49M | Buy |
24,929
+15,045
| +152% | +$2.71M | 0.02% | 305 |
|
|
2024
Q4 | $1.55M | Hold |
9,884
| – | – | 0.01% | 497 |
|
|
2024
Q3 | $1.8M | Sell |
9,884
-100
| -1% | -$18.2K | 0.01% | 485 |
|
|
2024
Q2 | $1.83M | Sell |
9,984
-230
| -2% | -$42.2K | 0.01% | 477 |
|
|
2024
Q1 | $1.82M | Buy |
10,214
+629
| +7% | +$112K | 0.01% | 520 |
|
|
2023
Q4 | $1.19M | Sell |
9,585
-538
| -5% | -$66.7K | ﹤0.01% | 624 |
|
|
2023
Q3 | $1.17M | Sell |
10,123
-5,839
| -37% | -$677K | 0.01% | 585 |
|
|
2023
Q2 | $1.87M | Buy |
+15,962
| New | +$1.87M | 0.01% | 503 |
|